Evidence map›Paper›PMID 38628624›Full record

ArticleComputing in cardiology2023

Deep Learning System for Left Ventricular Assist Device Candidate Assessment from Electrocardiograms.

Antonio Mendoza, Mehdi Razavi, Joseph R Cavallaro

Abstract read
In one paragraph

Article in Computing in cardiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Real-time On-device Inference for ECG Classification of Ventricular Dysfunction.Conference record. Asilomar Conference on Signals, Systems & Computers · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Antonio MendozaRice University, Houston, TX, United States.
Mehdi RazaviTexas Heart Institute, Houston, TX, United States.
Joseph R CavallaroRice University, Houston, TX, United States.

Funding

Maglev LVAD with expandable stented inlet and anti-thrombotic coating to improve hemocompatibilityR01HL166724 · NHLBI · TEXAS HEART INSTITUTE · PI Joseph R. Cavallaro, Lakshmi Prasad Dasi · 2023 to 2026
$2.8M
NHLBI NIH HHS R01 HL166724
6 · The paper itself

Abstract

Left Ventricular Assist Devices (LVADs) are increasingly used as long-term implantation therapy for advanced heart failure patients, where candidacy assessment is crucial for successful treatment and recovery. A Deep Learning system based on Electrocardiogram (ECG) diagnoses criteria to stratify candidacy is proposed, implementing multi-model processing, interpretability, and uncertainty estimation. The approach includes beat segmentation for single-lead classification, 12-lead analysis, and semantic segmentation, achieving state-of-the-art results on the classification evaluation of each model, with multilabel average AUC results of 0.9924, 0.9468, and 0.9956, respectively, presenting a novel approach for LVAD candidacy assessment, serving as an aid for decision-making.

Identifiers

PMID38628624
PMCPMC11021018

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.